DiagnaMed Holdings Corp
OTC:DGNMF
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
D
|
DiagnaMed Holdings Corp
OTC:DGNMF
|
CA |
|
ENvue Medical Inc
NASDAQ:FEED
|
US |
|
S
|
St Joe Co
XMUN:JOE
|
US |
|
Mistras Group Inc
NYSE:MG
|
US |
|
Coast Entertainment Holdings Ltd
ASX:CEH
|
AU |
|
C
|
Commonwealth Bank of Australia
XMUN:CWW
|
AU |
|
Essential Properties Realty Trust Inc
F:2OU
|
US |
Intrinsic Value
Is DGNMF undervalued or overvalued?
See the intrinsic value estimate for DiagnaMed Holdings Corp and find out whether today’s valuation is cheap or expensive by its own historical standards.
Do our valuations actually work? See backtest results .
Fundamental Analysis
What DiagnaMed Does
DiagnaMed Holdings Corp. is a biotechnology company, which engages in the development and commercialization of digital therapeutics for mental health and neurological disorders. The company is headquartered in Vancouver, British Columbia. The company went IPO on 2022-11-08. The firm is developing a platform of software-based prescription digital therapeutic products (PDT Products) for detecting brain age and tremors for neurological disorders.
- Headquarters
- Canada CA
- IPO date
- Nov 8, 2022
Earnings Waterfall
DiagnaMed Holdings Corp
The intrinsic value for DiagnaMed Holdings Corp (DGNMF) under the Base Case is hidden USD.
Compared with the current market price of 0.0214 USD, the stock appears hidden.